Welcome back to the blog companion for the MedTech Podcast! In today's post, we are diving deep into a quarter-century of evolution within the medical device industry. When we look back at the last twenty-five years, the pace of technological advanc…
Every wearable on the market promises to measure something clinically meaningful: heart rate variability, oxygen saturation, sleep, arrhythmia risk. The harder question for a sponsor is whether that number will hold up as evidence in a clinical tria…
A useful clinical strategy is not just scientifically sound. It also has to survive contact with real patients, real sites, real timelines, and real failures. In their conversation with Jesús E. Moreno on Global Trial Accelerators, Joseph Grieco, th…
In this Global Trial Accelerators episode, Jesús E. Moreno speaks with Pablo Yarza, founder of BIOINFILE, about a problem that sits underneath nearly every biomedical program: teams cannot move faster than the data they can actually trust. That sou…
In this episode, Julio Martinez-Clark asks James F. Jordan whether medtech companies should still look to Europe first, and what that choice means for Latin America. Jordan, who was President & CEO of Pittsburgh Life Sciences Greenhouse and a profes…
For MedTech leaders, Latin America can look tempting from far away and confusing up close. In his conversation with Julio Martinez-Clark, Michael Ford makes the case that growth in the region is possible, but only if companies replace broad regional…
For many MedTech companies, Latin America still gets treated as an export afterthought: meet a distributor at a trade show, sign an agreement, ship product, and hope demand appears. In this conversation with Julio Martinez-Clark, Joseph D. Storer, w…
John Hendrick has spent decades in medical devices, from startups to larger corporate roles. In this conversation with Julio Martinez-Clark, recorded when he was President of Safeco, a medical device consulting company, he offers a practical view of…
For MedTech founders, Latin America is often described as a growth region. That is true, but it can also be misleading. In his conversation with Julio Martinez-Clark, Rahul Modi, then founder and CEO of Envision, talks less about abstract opportunit…
Jonathan Rourke, who was co-founder and CEO of MitraSpan when this episode was recorded, does something useful in this episode: he narrows the Latin America conversation. He is not presenting the region as a generic shortcut. He is describing where …
International expansion often sounds simple until a company has to choose markets, find distributors, register products, and get shipments through customs. In this episode, Zach Selch, who was VP of Global Sales for a high-tech medical company when …
For founders and commercial leaders, Latin America can look close, familiar, and tempting. But in this episode, Julio Martinez-Clark’s conversation with Michael Benzaken makes a useful correction: proximity is not a strategy. Benzaken, introduced i…
For MedTech leaders, Latin America is often discussed as if it were a single expansion decision: enter or do not enter. In this episode, Julio Martinez-Clark speaks with Lloyd Diamond, who was President and CEO of Precise Light Surgical when the epi…
Latin America is often discussed as one big expansion play, but Michael Barbe makes a more useful point in his conversation with Julio Martinez-Clark: the region rewards companies that plan for execution, not just ambition. In this episode, Barbe, t…
For device companies that see Latin America as a simple export destination, this episode is a useful reset. Julio Martinez-Clark talks with Francisco Peralta, who was a principal at Ethos Consulting at the time of the interview, about what actually …
Latin America is often discussed as if it were one market. In this episode, Alejandro Infante explains why that mindset creates bad decisions. Speaking with Julio Martinez-Clark, he draws on decades of operating experience at Abbott Laboratories, Ho…
Latin America often gets described as a future opportunity for device makers, but this episode makes a more practical point: growth in the region does not come from showing up late with a product and hoping a distributor can do the rest. In his conv…
In this episode of the then-named LATAM MedTech Leaders podcast, Julio Martinez-Clark speaks with Steve Garchow, then President of Foresight Business Consulting, about what it actually takes to commercialize medical products in Latin America. The co…
Most AI coverage in medicine starts with scale: larger models, larger datasets, larger computing budgets. In this Global Trial Accelerators episode, Jesús E. Moreno talks with Dr. Joseph Geraci, CSO/CTO & Co-Founder at NetraMark, about a less comfor…
CNS drug development has a science problem and an execution problem. In this episode of Global Trial Accelerators, Gary K. Zammit, founder and CEO of Clinilabs and author of Beyond the Science, argues that many sponsors spend too much time polishing…
In this episode of Global Trial Accelerators, Jesús E. Moreno speaks with Alfonso García of Leon Research about a mistake that shows up again and again in international studies: assuming a protocol can travel unchanged from one market to another. Ga…
Healthcare startups are often discussed as if the best idea naturally rises to the top. In his conversation with Jesús E. Moreno, Steven Collens argues for a less romantic and more useful view: innovation depends on infrastructure. On the episode pa…
Many conversations about trial recruitment still start with the same assumptions: open more sites, buy more media, and hope more patients respond. In his conversation with Jesús E. Moreno on this episode page, Scott Stout, CEO & Co-Founder at MedVec…
If you work on early-stage medical devices, geography is never just geography. It is a decision about evidence, timing, operator access, cost, and what regulators will accept next. In this episode, Laura Minarsch brings that tradeoff into focus from…